How oncologically resistant.
Oncological patients are at high risk of infection due to their own disease characteristics and the effects of anti-oncological treatment. Effective anti-infection is essential to improve the prognosis of oncology patients and to guarantee the smooth running of anti-oncological treatment.
The tumor itself weakens the body defense. On the one hand, as tumours progress, cancer cells deplete the body ‘ s nutrients, leading to malnutrition among patients, and on the other hand, the lack of proteins, vitamins, etc., limits immunosuppressive factors, disrupts the normal functioning of the immune system, inhibits immunosuppressive cytoactivity and reduces the body ‘ s resilience to alien pathogens.
Anti-tumour treatment is even more “aggravated”. Chemopharmaceutical drugs, while killing cancer cells, also cause damage to normal, rapidly growing cells, such as bone marrow stem cells, resulting in a decrease in white cells, meso-particle cells and a sharp increase in the risk of infection when their absolute value is below 0.5 x 109/L, a stage known as the lack of particle cells. The dermal, mucous membrane, which can cause damage to the part of the exposure, destroys the local barrier and opens the door to pathogens such as bacteria and fungi, such as the fracture of the mucous mucous membrane following the treatment of the neck, which can cause oral infections. Surgery, as an important means of treatment for oncology, can also breed bacteria and lead to infection if post-surgery incisions are poorly healed.
In the light of the above factors, the anti-infection of oncology patients requires a multipronged approach.
The first is the prevention dimension. The daily diet of patients is balanced in nutrition and increases the intake of good quality proteins, such as skinny meat, fish, eggs, dairy products, more fresh vegetables and fruits, as well as the supply of vitamins and minerals, maintaining good health and increasing immunity. The living environment should be kept clean and regularly ventilated in order to reduce the growth of pathogens and minimize the risk of infection by reaching places that are densely populated and inaccessible. Physicosanitary care must be taken and hand-washed, especially before entering the outside world, using soap or alcohol-containing hand-washing fluids, is a simple step that can effectively stop many pathogens.
During anti-oncological treatment, the patient ‘ s blood routines and immunological function indicators are closely monitored by medical personnel. When white cells are found to be decreasing, the use of particle-cell concentration irritation factors, where appropriate, to increase the number of white cells, is also a key strategy for the early and preventive use of antibiotics, which can significantly reduce the incidence of infection by giving experiential antibiotics, depending on the patient ‘ s individual circumstances, prior to the onset of the particle-cell shortage. In the case of patients with leachation, care is provided for skin mucous membranes in radioactive areas, e.g., when the neck is administered, the mouth is brackished, the mouth is kept clean, drugs for healing are partially painted and oral infections are prevented; when pelvis is administered, care is taken to keep the vagina healthy and to prevent infection with the urinary system.
Timely and accurate diagnosis is a first step in the event of an unfortunate infection. Patients who have symptoms such as fever, cough, abdominal pain, diarrhoea should be treated as soon as possible, with detailed information on the doctor ‘ s history of oncology, treatment, the doctor ‘ s combination of clinical symptoms, signs, laboratory examinations, including blood patterns, C reaction proteins, calcium, blood culture, abdominal culture, urine culture, etc., and the type of infection and pathogens will be determined by means of visual means such as X-line, CT, etc.
In treatment, the best choice of antibiotics based on drug sensitivity results is most important. Due to the complexity and diversity of pathogen infections among oncologists, drug resistance occurs at times, and empirical drug use must be adjusted in a timely manner to ensure the effectiveness of antibacterial drugs. In the case of fungi infections, the choice of anti-facter drugs is equally prudent, taking into account the side effects of the drug and the patient ‘ s resistance, such as sex cycin B, which has a wide spectrum of resistance, but has higher kidney toxicity, which requires a trade-off. In the fight against infection, it is not possible to ignore support for treatment, supplementing lost nutrition through intestine or intestine nutrition, correcting hydrolytic disorders, and, if necessary, introducing added body resistance such as immunoprotein, helping patients to overcome the infection, creating conditions for subsequent anti-oncological treatment, extending the life cycle and improving the quality of life.
